Back to Search Start Over

Functional resilience of C57BL/6J mouse heart to dietary fat overload.

Authors :
Tadinada, Satya Murthy
Weatherford, Eric T.
Collins, Greg V.
Bhardwaj, Gourav
Cochran, Jesse
Kutschke, William
Zimmerman, Kathy
Bosko, Alyssa
O'Neill, Brian T.
Weiss, Robert M.
Abel, E. Dale
Source :
American Journal of Physiology: Heart & Circulatory Physiology; Nov2021, Vol. 321 Issue 5, pH850-H864, 15p
Publication Year :
2021

Abstract

Molecular mechanisms underlying cardiac dysfunction and subsequent heart failure in diabetic cardiomyopathy are incompletely understood. Initially we intended to test the role of G protein-coupled receptor kinase 2 (GRK2), a potential mediator of cardiac dysfunction in diabetic cardiomyopathy, but found that control animals on HFD did not develop cardiomyopathy. Cardiac function was preserved in both wild-type and GRK2 knockout animals fed high-fat diet as indicated by preserved left ventricular ejection fraction (LVEF) although heart mass was increased. The absence of cardiac dysfunction led us to rigorously evaluate the utility of diet-induced obesity to model diabetic cardiomyopathy in mice. Using pure C57BL/6J animals and various diets formulated with different sources of fat-lard (32% saturated fat, 68% unsaturated fat) or hydrogenated coconut oil (95% saturated fat), we consistently observed left ventricular hypertrophy, preserved LVEF, and preserved contractility measured by invasive hemodynamics in animals fed high-fat diet. Gene expression patterns that characterize pathological hypertrophy were not induced, but a modest induction of various collagen isoforms and matrix metalloproteinases was observed in heart with high-fat diet feeding. PPARa-target genes that enhance lipid utilization such as Pdk4, CD36, AcadL, and Cpt1b were induced, but mitochondrial energetics was not impaired. These results suggest that although long-term fat feeding in mice induces cardiac hypertrophy and increases cardiac fatty acid metabolism, it may not be sufficient to activate pathological hypertrophic mechanisms that impair cardiac function or induce cardiac fibrosis. Thus, additional factors that are currently not understood may contribute to the cardiac abnormalities previously reported by many groups. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03636135
Volume :
321
Issue :
5
Database :
Complementary Index
Journal :
American Journal of Physiology: Heart & Circulatory Physiology
Publication Type :
Academic Journal
Accession number :
153089892
Full Text :
https://doi.org/10.1152/ajpheart.00419.2021